A detailed history of Lvz, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Lvz, Inc. holds 820 shares of LLY stock, worth $745,650. This represents 0.1% of its overall portfolio holdings.

Number of Shares
820
Previous 830 1.2%
Holding current value
$745,650
Previous $645,000 15.04%
% of portfolio
0.1%
Previous 0.09%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$724.87 - $909.04 $7,248 - $9,090
-10 Reduced 1.2%
820 $742,000
Q1 2024

Apr 17, 2024

SELL
$592.2 - $792.28 $2,961 - $3,961
-5 Reduced 0.6%
830 $645,000
Q4 2023

Jan 23, 2024

BUY
$525.19 - $619.13 $151,254 - $178,309
288 Added 52.65%
835 $486,000
Q3 2023

Nov 08, 2023

SELL
$434.7 - $599.3 $19,996 - $27,567
-46 Reduced 7.76%
547 $293,000
Q2 2023

Jul 18, 2023

SELL
$350.74 - $468.98 $7,014 - $9,379
-20 Reduced 3.26%
593 $278,000
Q1 2023

Apr 20, 2023

BUY
$310.63 - $364.82 $5,591 - $6,566
18 Added 3.03%
613 $210,000
Q4 2022

Jan 17, 2023

BUY
$321.55 - $374.67 $191,322 - $222,928
595 New
595 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lvz, Inc. Portfolio

Follow Lvz, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvz, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lvz, Inc. with notifications on news.